|
|
|
|
|
The Niche
|
Stem Cell & Regenerative Med Newsletter
|
|
|
|
|
|
Weekly reads: stem cell good news, bad news on sickle cell, MS, IPSCs
|
|
|
|
Let's start with some stem cell good news on evolving approaches to treat sickle cell disease involving stem cells. Then on another related front things were more concerning. https://www.youtube.com/watch?v=F871t8c4mHk Stem cell good news on sickle cell disease, a complication Sickle Cell Disease News reports Adding Briquilimab Boosts Success of Sickle Cell Stem Cell Transplant. This is a story some of enhancing …
|
|
|
|
|
|
|
|
3rd Invitrx warning highlights FDA oversight weakness
|
|
|
|
The FDA seems oddly slow in oversight of unproven stem cell clinic-related firms like one here in California called Invitrx Therapeutics. I've written before about Invitrx, but interactions between them and the FDA have continued including a new warning letter. It's become a puzzling situation. More broadly, the FDA has done relatively little in the past two years on unproven stem …
|
|
|
|
|
|
